Dipeptidyl Peptidase 4 Inhibitors and Venous Thromboembolism Risk in Patients with Type 2 Diabetes: A Meta-analysis of Cardiovascular Outcomes Trials

Thromb Haemost. 2021 Jan;121(1):106-108. doi: 10.1055/s-0040-1715444. Epub 2020 Aug 9.

Li Xin¹, Shusen Sun^{2

3

4}, Jinwen Wang¹, Wenchao Lu^{5

6}, Tiansheng Wang⁷, Huilin Tang⁸

¹ Department of Clinical Pharmacy, The Second People's Hospital of Yunnan Province, Kunming, Yunnan, China.
² College of Pharmacy and Health Sciences, Western New England University, Springfield, Massachusetts, United States.
³ Department of Pharmacy, Xiangya Hospital, Central South University, Changsha, Hunan, China.
⁴ The Hunan Institute of Pharmacy Practice and Clinical Research, Changsha, Hunan, China.
⁵ Department of Pharmacy, Beijing Chaoyang Hospital, Capital Medical University, Beijing, China.
⁶ Department of Pharmacy Administration and Clinical Pharmacy, School of Pharmaceutical Sciences, Peking University, Beijing, China.
⁷ Department of Epidemiology, Gillings School of Global Public Health, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina, United States.
⁸ Institute for Drug Evaluation, Peking University Health Science Center, Beijing, China.

No abstract available

Publication types